Actinogen Medical Limited (ACW.AX) — Stock Score Summary

Actinogen Medical Limited (ACW.AX) has a MoatMap StockRank of 12/100 based on Quality (35/100), Value (32/100), and Momentum (29/100) factor scores. The current signal is STRONG SELL. Actinogen Medical is a microcap biotech focused on Alzheimer's research; it is highly speculative with binary clinical trial risks and does not meet our quality or cash-flow criteria.

Actinogen Medical Limited develops novel therapies for neurological and neuropsychiatric diseases associated with chronically elevated cortisol, primarily focusing on its lead drug candidate, Xanamem. The company holds a strong intellectual property portfolio around its selective 11β-HSD1 inhibitor platform, targeting high-barrier indications like Alzheimer's disease and depression. It is a clinical-stage biotechnology company targeting high-value, unmet medical needs in the cognitive health sector.

Key Financial Metrics

Price$0.02
Market Cap$98M
P/E (Forward)-3.60
Price/Book12.00
Return on Equity-110.8%
Return on Invested Capital-79.3%
Debt/Equity2.67
Gross Margin100.0%
Operating Margin-608.6%
Free Cash Flow$-5M

Actinogen Medical Limited operates in the Biotechnology industry, part of the Healthcare sector (Australia).

Frequently Asked Questions

What is Actinogen Medical Limited’s (ACW.AX) StockRank?
MoatMap’s StockRank for Actinogen Medical Limited (ACW.AX) is 12/100, with a Strong Sell signal. It is a composite of Quality (35), Value (32), and Momentum (29) factor ranks across MoatMap’s 19,000+ stock universe.
Does Actinogen Medical Limited have an economic moat?
Actinogen Medical Limited (ACW.AX) has a Quality factor score of 35/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Actinogen Medical Limited a buy, hold, or sell?
MoatMap’s current signal for Actinogen Medical Limited (ACW.AX) is Strong Sell, based on a StockRank of 12/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Actinogen Medical Limited in?
Actinogen Medical Limited (ACW.AX) operates in the Healthcare sector, specifically the Biotechnology industry (Australia).
Browse all ranked stocksACW.AX deep dive reportAI ChampionsHow we score stocksSense-check another stock